 |
| 1030 Massachusetts Avenue, Cambridge, MA |
 |
| Greg LaBine |
BOSTON, MA –– Holliday
Fenoglio Fowler, L.P. (HFF) announced it has arranged $51 million in
recapitalization financing for 1030
Massachusetts Avenue, a 77,805-square-foot, Class A,
laboratory/biotechnology building within walking distance of Harvard Square in
Cambridge, Massachusetts.
Working on behalf of the
borrower, an affiliate of Longfellow Real Estate Partners, HFF placed the
five-year, fixed-rate loan with Capital One Healthcare.
1030 Massachusetts Avenue
was renovated into a Class A biotech/laboratory building to cater to the high
tech bio tenant base in the surrounding Cambridge market. The four-story property is fully leased to
seven tenants: five biotech tenants, an indoor cycling studio, and a restaurant
slated to open in early summer 2016.
Situated within walking distance of both
Harvard and Central Squares, 1030 Massachusetts Avenue has convenient access to
numerous restaurants, shopping, and entertainment as well as public
transportation providing access to downtown Boston, just three miles southeast.
“Speed to closing was one
of the critical elements for Longfellow.
From the beginning of HFF’s marketing process to the closing was a span
of only 49 days,” said Greg LaBine,
managing director of HFF. “Capital One
moved very quickly and efficiently, dual tracking due diligence and legal to
make this happen.”
For a complete copy of the company’s news release,
please contact:
Kristen M. Murphy
Director, Marketing
HFF | One Post Office
Square, Suite 3500 | Boston, MA 02109
Main: 617-338-0990 |
Direct: 617-848-1572 | Cell: 617-543-4873 | www.hfflp.com
No comments:
Post a Comment